Recombinant CEACAM5 (Tusamitamab Biosimilar) antibody
Quick Overview for Recombinant CEACAM5 (Tusamitamab Biosimilar) antibody (ABIN7538086)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Tusamitamab Biosimilar - Anti-CEACAM5 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CEACAM5 (Tusamitamab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine, which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).
-
CAS-No
- 2349294-95-5
Target
-